Point72 Hong Kong LTD Pfizer Inc Call Options Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $5.54 Million - $6.77 Million	-126,700 Reduced 86.48%	19,800 $866,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $5.54 Million - $6.77 Million	-126,700 Reduced 86.48%	19,800 $866,000
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $2.94 Million - $3.49 Million	-63,200 Reduced 30.14%	146,500 $7.68 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $3.17 Million - $3.92 Million	69,200 Added 49.25%	209,700 $10.9 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $3.97 Million - $5.88 Million	-96,000 Reduced 40.59%	140,500 $8.3 Million

Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $5.87 Million - $7.54 Million	149,500 Added 171.84%	236,500 $10.2 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $962,387 - $1.09 Million	26,800 Added 44.52%	87,000 $3.41 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $1.3 Million - $1.46 Million	-38,700 Reduced 39.13%	60,200 $2.18 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $3.31 Million - $4.21 Million	98,900 New	98,900 $3.64 Million

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.